Abbott’s Lupron, a long-acting treatment for premature puberty, received FDA approval
On Tuesday, Abbott Laboratories announced that two longer-acting doses of Lupron, a treatment for premature puberty, have been approved by
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine